Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

Abstract

CHEMOKINES are chemotactic cytokines that activate and direct the migration of leukocytes1,2. There are two subfamilies, the CXC and the CC chemokines. We recently found that the CXC-chemokine stromal cell-derived factor-1 (SDF-1)3,4 is a highly efficacious lymphocyte chemoattractant5. Chemokines act on responsive leukocyte subsets through G-protein-coupled seven-transmembrane receptors1, which are also used by distinct strains of HIV-1 as cofactors for viral entry. Laboratory-adapted and some T-celi-line-tropic (T-tropic) primary viruses use the orphan chemokine receptor LESTR/fusin (also known as fusin)6–8, whereas macrophage-tropic primary HIV-1 isolates use CCR-5 and CCR-3 (refs 7–11), which are receptors for known CC chemokines. Testing of potential receptors demonstrated that SDF-1 signalled through, and hence 'adopted', the orphan receptor LESTR, which we therefore designate CXC-chemokine receptor-4 (CXCR-4). SDF-1 induced an increase in intracellular free Ca2+ and chemotaxis in CXCR-4-transfected cells. Because SDF-1 is a biological ligand for the HIV-1 entry cofactor LESTR, we tested whether it inhibited HIV-1. SDF-1 inhibited infection by T-tropic HIV-1 of HeLa-CD4 cells, CXCR-4 transfectants, and peripheral blood mononuclear cells (PBMCs), but did not affect CCR-5-mediated infection by macrophage-tropic (M-tropic) and dual-tropic primary HIV-1.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Baggiolini, M., Dewald, B. & Moser, B. Adv. Immunol. 55, 97–179 (1994).

    CAS  Article  Google Scholar 

  2. Springer, T. A. Annu. Rev. Physiol. 57, 827–872 (1995).

    CAS  Article  Google Scholar 

  3. Tashiro, K. et al. Science 261, 600–603 (1993).

    ADS  CAS  Article  Google Scholar 

  4. Nagasawa, T., Kikutani, H. & Kishimoto, T. Proc. Natl Acad. Sci. USA 91, 2305–2309 (1994).

    ADS  CAS  Article  Google Scholar 

  5. Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A. & Springer, T. A. J. Exp. Med. (in the press).

  6. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. Science 272, 872–877 (1996).

    ADS  CAS  Article  Google Scholar 

  7. Choe, H. et al. Cell 85, 1135–1148 (1996).

    CAS  Article  Google Scholar 

  8. Doranz, B. J. et al. Cell 85, 1149–1158 (1996).

    CAS  Article  Google Scholar 

  9. Dragic, T. et al. Nature 381, 667–673 (1996).

    ADS  CAS  Article  Google Scholar 

  10. Deng, H. et al. Nature 381, 661–666 (1996).

    ADS  CAS  Article  Google Scholar 

  11. Alkhatib, G. et al. Science 272, 1955–1958 (1996).

    ADS  CAS  Article  Google Scholar 

  12. Shirozu, M. et al. Genomics 28, 495–500 (1995).

    CAS  Article  Google Scholar 

  13. Roth, S. J., Carr, M. W., Rose, S. S. & Springer, T. A. J. Immunol. Methods 100, 97–116 (1995).

    Article  Google Scholar 

  14. Herzog, H. et al. Proc. Natl Acad. Sci. USA 89, 5794–5798 (1992).

    ADS  CAS  Article  Google Scholar 

  15. Federsppiel, B. et al. Genomics 16, 707–712 (1993).

    CAS  Article  Google Scholar 

  16. Jazin, E. E. et al. Regul. Pept. 47, 247–258 (1993).

    CAS  Article  Google Scholar 

  17. Nomura, H., Nielsen, B. W. & Matsushima, K. Int. Immunol. 5, 1239–1249 (1993).

    CAS  Article  Google Scholar 

  18. Loetscher, M. et al. J. Biol. Chem. 269, 232–237 (1994).

    CAS  Google Scholar 

  19. Helseth, E. et al. J. Virol. 64, 2416–2420 (1990).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Loetscher, M. et al. J. Exp. Med. (in the press).

  21. Nagasawa, T. et al. Nature 382, 635–638.

  22. Rimland, J. et al. Mol. Pharmacol. 40, 869–875 (1991).

    CAS  PubMed  Google Scholar 

  23. Cocchi, F. et al. Science 270, 1811–1815 (1995).

    ADS  CAS  Article  Google Scholar 

  24. Asjo, B. et al. Lancet (ii), 660–662 (1986).

  25. Schuitemaker, H. et al. J. Virol. 65, 356–363 (1991).

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Clark-Lewis, I. et al. Biochem. J. 30, 3128–3135 (1991).

    CAS  Article  Google Scholar 

  27. Yenush, L., Kundra, V., White, M. F. & Zetter, B. R. J. Biol. Chem. 269, 100–104 (1994).

    CAS  PubMed  Google Scholar 

  28. Parolin, C., Dorfman, T. Palú, G., Gottlinger, H. & Sodroski, J. J. Virol. 68, 3888–3895 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Parolin, C., Taddeo, B., Palú, G. & Sodroski, J. Virol. 222, (in the press).

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bleul, C., Farzan, M., Choe, H. et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829–833 (1996). https://doi.org/10.1038/382829a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/382829a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing